World Asthma Day 2024 - Asthma Education Empowers
Published in General & Internal Medicine
Despite strides in therapeutic development for asthma management, its morbidity and mortality persistently rise, particularly burdening low- and middle-income countries. To address this pressing need for deeper insight into asthma pathogenesis and therapeutic targets, Respiratory Research presents two focused issues that showcase cutting-edge discoveries in the field. The findings presented in both collections, “Asthma: Towards a Cure” and “Human Precision Cut Lung Slices: an Ex Vivo Platform for Therapeutic Target Discovery and Drug Testing in Lung Disease” will provide exciting discoveries furthering education and speaking to the theme of this year’s World Asthma Day – Asthma Education Empowers.
The first themed collection, "Asthma: Towards a Cure," compiles manuscripts delving into innovative science aimed at addressing the unmet challenge of managing and ultimately curing asthma. Within this collection, authors unveil novel biomarkers predicting therapeutic responses to both emerging and established treatments. Encompassing fundamental, translational, and clinical studies, these manuscripts not only disseminate new approaches but also strive to influence clinical practice and policy.
The second issue, "Human Precision Cut Lung Slices: an Ex Vivo Platform for Therapeutic Target Discovery and Drug Testing in Lung Disease,” spotlights the utility of an experimental platform mirroring the complexities of the in vivo lung environment. While precision cut lung slices (PCLS) have been utilized in respiratory research since the late 1970s, recent innovations have propelled their acceptance and expanded their applications across various domains. From toxicology and drug discovery to lung cancer biology and respiratory pathogen exposure, PCLS derived from both animal models and human lungs have significantly enhanced our understanding of integrated cellular responses, elucidating fundamental mechanisms in lung biology and providing a platform for therapeutic discovery.
Given the global impact of asthma, Respiratory Research is committed to sharing breakthroughs in asthma research, thereby contributing to the advancement of global health initiatives and providing education to both the scientific community and the general public to empower everyone to combat this disease.
Cynthia Koziol-White and Reynold A. Panettieri, Jr.
Rutgers University, New Brunswick, New Jersey USA
Follow the Topic
-
Respiratory Research
This journal publishes high-quality clinical and basic research, review and commentary articles on all aspects of respiratory medicine and related diseases.
Related Collections
With Collections, you can get published faster and increase your visibility.
Advancing Respiratory Pathogen Surveillance and Discovery in the Middle East and Africa
The journal Respiratory Research is seeking contributions for a Collection focused on advancing the surveillance, detection, and discovery of respiratory pathogens, encompassing viral, bacterial, and other clinically significant agents. This initiative aims to deepen understanding of the epidemiology, transmission, and impact of respiratory infections across the diverse ecological, demographic, and socio-economic landscapes of the Middle East and Africa.
Despite their central role in global respiratory disease burden, these regions remain underrepresented in pathogen discovery efforts and surveillance data generation. Addressing these gaps is essential not only for regional health security but also for strengthening global preparedness against emerging and re-emerging respiratory threats.
We welcome original research articles, research reports, and comprehensive reviews that contribute to this critical and evolving field. Topics of interest include, but are not limited to:
- Innovative diagnostic and pathogen detection technologies (including multiplex, genomic, and point-of-care approaches)
- Integrated and community-based surveillance systems for respiratory infections
- Transmission dynamics of respiratory pathogens across healthcare and community settings
- Interactions between viral and bacterial pathogens, including co-infections and secondary infections
- Socio-economic, environmental, and behavioural determinants of respiratory pathogen spread
- Antimicrobial resistance in respiratory bacterial pathogens and its clinical and public health implications
- Integrative, multi-pathogen approaches to respiratory public health and outbreak response
- Regional and international collaborative research frameworks
- Capacity building, education, and workforce development in respiratory epidemiology and microbiology
- Data sharing, interoperability, and equity in access to surveillance data
This Collection supports and amplifies research related to SDG 3: Good health and well-being.
All submissions in this Collection undergo the journal’s standard peer review process. Similarly, all manuscripts authored by a Guest Editor(s) will be handled by the Editor-in-Chief. As an open access publication, this journal levies an article processing fee (details here). We recognize that many key stakeholders may not have access to such resources and are committed to supporting participation in this issue wherever resources are a barrier. For more information about what support may be available, please visit OA funding and support, or email OAfundingpolicy@springernature.com or the Editor-in-Chief.
Publishing Model: Open Access
Deadline: Feb 04, 2027
Familial pulmonary fibrosis
The journal Respiratory Research invites contributions to a special collection centred on "Familial Pulmonary Fibrosis". This collection aims to deepen insights into the genetic underpinnings of pulmonary fibrosis, particularly exploring telomere and surfactant biology disorders and the progressive fibrosing phenotype. The impact of pathogenic variants in Telomerase and Surfactant Related Genes, alongside the development of effective antifibrotic therapies, forms a crucial part of this research landscape. Topics of interest include but are not limited to:
- Genetic predisposition in familial pulmonary fibrosis
- Epidemiology of familial pulmonary fibrosis
- Role of telomere biology disorders
- Role of surfactant biology disorders
- Implications of Telomerase Related Genes variants
- Implications of Surfactant Related Genes variants
- Mechanisms behind the progressive fibrosing phenotype
- Response to antifibrotic therapies
- Interstitial lung diseases and their familial aspects
- Biomarkers for early detection
- Development of registries in familial pulmonary fibrosis
- Clinical management strategies
This Collection supports and amplifies research related to SDG 3: Good health and well-being.
All submissions in this Collection undergo the journal’s standard peer review process. Similarly, all manuscripts authored by a Guest Editor(s) will be handled by the Editor-in-Chief. As an open access publication, this journal levies an article processing fee (details here). We recognize that many key stakeholders may not have access to such resources and are committed to supporting participation in this issue wherever resources are a barrier. For more information about what support may be available, please visit OA funding and support, or email OAfundingpolicy@springernature.com or the Editor-in-Chief.
Publishing Model: Open Access
Deadline: Jan 22, 2027
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in